ViewRay, Inc. (VRAY)
Stock Price:
$3.28 USD
0.02 (0.61%)
Updated Aug 13, 2020 4:00 PM EDT - Market closed
After-hours: $3.27 -0.01 (-0.31%) Aug 13, 5:12 PM
Key Info
| Market Cap |
485.26M |
| Revenue (ttm) |
65.81M |
| Net Income (ttm) |
-109.72M |
| Shares Out |
147.94M |
| EPS (ttm) |
-0.86 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 13, 2020 |
| Last Price |
$3.28 |
| Previous Close |
$3.26 |
| Change ($) |
0.02 |
| Change (%) |
0.61% |
| Day's Open |
3.26 |
| Day's Range |
3.17 - 3.32 |
| Day's Volume |
923,622 |
| 52-Week Range |
1.11 - 4.88 |
More Stats
| Market Cap |
485.26M |
| Enterprise Value |
371.17M |
| Earnings Date (est) |
Nov 16, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
147.94M |
| Float |
92.69M |
| EPS (basic) |
-0.89 |
| EPS (diluted) |
-0.86 |
| FCF / Share |
-0.54 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
17.48M |
| Short Ratio |
13.80 |
| Short % of Float |
17.58% |
| Beta |
0.89 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
7.37 |
| PB Ratio |
2.81 |
| Revenue |
65.81M |
| Operating Income |
-119.76M |
| Net Income |
-109.72M |
| Free Cash Flow |
-79.79M |
| Net Cash |
114.09M |
| Net Cash / Share |
0.77 |
| Gross Margin |
3.68% |
| Operating Margin |
-181.99% |
| Profit Margin |
-166.70% |
| FCF Margin |
-121.26% |
| ROA |
-25.62% |
| ROE |
-73.90% |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (9)
| Buy |
5 |
| Overweight |
0 |
| Hold |
3 |
| Underweight |
0 |
| Sell |
1 |
Analyst Consensus: Overweight
Price Target
$3.61*
(10.06% upside)
Low
2.00
Current: $3.28
High
7.00
Target: 3.61
*Average 12-month price target from 7 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|
| Revenue | 87.78 | 80.96 | 34.04 | 22.24 | 10.39 | 6.40 | 3.16 |
| Revenue Growth | 8.42% | 137.83% | 53.09% | 114.02% | 62.37% | 102.56% | - |
| Gross Profit | -5.48 | 6.60 | 6.33 | -3.63 | -4.15 | -2.75 | -5.03 |
| Operating Income | -121 | -75.09 | -48.16 | -44.18 | -41.43 | -31.58 | -27.10 |
| Net Income | -120 | -76.40 | -72.18 | -50.64 | -45.00 | -33.80 | -27.22 |
| Shares Outstanding | 102 | 81.12 | 58.46 | 40.07 | 17.43 | 0.89 | 0.82 |
| Earnings Per Share | -1.18 | -0.98 | -1.23 | -1.26 | -2.58 | -37.87 | -34.59 |
| Operating Cash Flow | -79.57 | -122 | -70.05 | -28.16 | -39.85 | -27.47 | -25.37 |
| Capital Expenditures | -7.82 | -3.69 | -2.16 | -7.04 | -4.26 | -2.00 | -1.70 |
| Free Cash Flow | -87.38 | -126 | -72.22 | -35.20 | -44.10 | -29.47 | -27.07 |
| Cash & Equivalents | 228 | 169 | 58.53 | 15.34 | 21.61 | 12.18 | 0.00 |
| Total Debt | 68.29 | 55.36 | 44.50 | 44.29 | 29.02 | 14.88 | - |
| Net Cash / Debt | 160 | 114 | 14.03 | -28.95 | -7.41 | -2.70 | 0.00 |
| Assets | 350 | 295 | 136 | 48.76 | 52.16 | 34.11 | - |
| Liabilities | 134 | 128 | 134 | 92.42 | 59.11 | 39.62 | - |
| Book Value | 216 | 167 | 1.99 | -43.65 | -6.96 | -151 | - |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
ViewRay, Inc. |
| Country |
United States |
| Employees |
309 |
| CEO |
Scott William Drake |
Stock Information
| Ticker Symbol |
VRAY |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: VRAY |
Description
ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio.